Cargando…
Cardiovascular co-morbidity in patients with rheumatic diseases
During recent years atherosclerosis, the major cause of cardiovascular disease (CVD), has been recognised as a chronic inflammatory condition in which rupture of atherosclerotic lesions appears to play a major role. The risk of CVD is raised in many rheumatic diseases. This risk is high in systemic...
Autor principal: | Frostegård, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218877/ https://www.ncbi.nlm.nih.gov/pubmed/21722331 http://dx.doi.org/10.1186/ar3326 |
Ejemplares similares
-
Cardiovascular co-morbidity in rheumatic diseases
por: Turesson, Carl, et al.
Publicado: (2008) -
Renal co-morbidity in patients with rheumatic diseases
por: Anders, Hans-Joachim, et al.
Publicado: (2011) -
Immunity, atherosclerosis and cardiovascular disease
por: Frostegård, Johan
Publicado: (2013) -
Systemic lupus erythematosus and cardiovascular disease
por: Frostegård, Johan
Publicado: (2022) -
IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases
por: Thiagarajan, Divya, et al.
Publicado: (2020)